Naina Lal Kidwai has resigned as independent director from the board of drug business CiplaNew Delhi: Drug major Cipla on Wednesday stated that Naina Lal Kidwai has resigned as independent director on its board, with impact from March 31, 2022.
In a letter shared by the Mumbai-based drug firm, the veteran banker kept in mind that she has actually put in her documents to fulfil several other duties and expert commitments.
I even more validate that there is no other reason for my resignation as an independent director of the business aside from as mentioned in this letter, Ms Kidwai added.